Travere Therapeutics, Inc. · NASDAQ:TVTX
Reed Elizabeth E sold 37,500 Travere Therapeutics, Inc. shares (Form 4)
Traded Sep 15, 2026 · Filed Sep 17, 2026
On Sep 15, 2026, Reed Elizabeth E (Chief Legal Officer and GC) sold 37,500 Travere Therapeutics, Inc. shares at an average US$62.34 for US$2.34M under a trading plan, leaving 105,389 shares. Filed Sep 17, 2026 (Form 4).
- Sold
- 37,500 shares
- Price
- US$62.34 average (US$62.03 to US$65.31)
- Value
- US$2.34M
- Holding after
- 105,389 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Legal Officer and GC
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | Option exercise | 37,500 | US$15.46 | 142,889 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 21,926 | US$62.03 | 120,963 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 13,874 | US$62.63 | 107,089 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 1,400 | US$63.69 | 105,689 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 300 | US$65.31 | 105,389 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Reed Elizabeth E
- Travere Therapeutics, Inc. shareholders
- Form 4 · Reed Elizabeth E · May 6, 2026
- Form 4 · Reed Elizabeth E · Apr 15, 2026
- Form 4 · Reed Elizabeth E · Apr 2, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026